Cefpodoxime Proxetil

Cefpodoxime proxetil is a third generation cephalosporin antibiotic targeting a wide variety of gram-negative and gram-positive organisms, especially those responsible for otitis media and pharyngitis. It is an ester prodrug of the free acid metabolite cefpodoxime.

Cephalosporins are a type of β-lactam antibiotic consisting of a four-membered β-lactam ring bound to a six-membered dihydrothiazine ring. This two-ring system causes distortion of the β-lactam amide bond, resulting in decreased resonance stabilization and increased reactivity. β-lactams inhibit the formation of peptidoglycan cross-links within bacterial cell walls by targeting penicillin-binding proteins or PBPs. Consequently, the bacterial cell wall becomes weak and cytolysis occurs. Cephalosporins are less susceptible to β-lactamases than the penicillin β-lactam antibiotics.

Antibiotics are often used in clinical in vitro tests known as antimicrobial susceptibility tests or ASTs to determine their efficacy against certain bacterial species. They are tested against gram-negative and gram-positive bacteria using panels, discs, and MIC strips by medical microbiologists. ASTs decrease the risk of using an antibiotic against bacteria exhibiting resistance to it, and the results are used in clinical settings to determine which antibiotic(s) to prescribe for various infections.

Product Specifications
Cefpodoxime Proxetil
Vantin® (Pfizer), Simplicef® (Pfizer)

MOLECULAR BIOLOGY GRADE

Formula: C₂₁H₂₇N₅O₉S₂

MW: 557.60 g/mol

Storage/Handling: Store at 2-8 °C. This product is light sensitive. Soluble in DMSO.

PubChem Chemical ID: 6526396